These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 8951215

  • 21. Long-term follow-up study of vigabatrin in pretreated children with West syndrome.
    Siemes H, Brandl U, Spohr HL, Völger S, Weschke B.
    Seizure; 1998 Aug; 7(4):293-7. PubMed ID: 9733404
    [Abstract] [Full Text] [Related]

  • 22. Optimizing the indication of vigabatrin in children with refractory epilepsy.
    Lortie A, Chiron C, Dumas C, Mumford JP, Dulac O.
    J Child Neurol; 1997 Jun; 12(4):253-9. PubMed ID: 9203067
    [Abstract] [Full Text] [Related]

  • 23. [New drugs in the treatment of childhood epilepsy: vigabatrin (study of 61 subjects)].
    Raucci U, Spalice A, Basile LA, Guardalà C, Nasta L, Terenzi S, Iannetti P.
    Pediatr Med Chir; 1994 Jun; 16(6):575-8. PubMed ID: 7708543
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The role of vigabatrin in childhood seizure disorders: results from a clinical audit.
    Prasad AN, Penney S, Buckley DJ.
    Epilepsia; 2001 Jan; 42(1):54-61. PubMed ID: 11207785
    [Abstract] [Full Text] [Related]

  • 29. Initial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of gamma-aminobutyric acid, glutamate, and glutamine in human brain.
    Petroff OA, Rothman DL, Behar KL, Mattson RH.
    Epilepsia; 1995 May; 36(5):457-64. PubMed ID: 7614922
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Antiepileptic drugs in development: prospects for the near future.
    Leppik IE.
    Epilepsia; 1994 May; 35 Suppl 4():S29-40. PubMed ID: 8174517
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Open label trial with vigabatrin in children with intractable epilepsy.
    Wong V.
    Brain Dev; 1995 May; 17(4):249-52. PubMed ID: 7503385
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Vigabatrin: 2008 update.
    Willmore LJ, Abelson MB, Ben-Menachem E, Pellock JM, Shields WD.
    Epilepsia; 2009 Feb; 50(2):163-73. PubMed ID: 19230067
    [Abstract] [Full Text] [Related]

  • 38. [In children with refractory epilepsy: vigabatrin or lamotrigine?].
    Caviedes BE, Herranz JL, Arteaga R, Armijo JA.
    Rev Neurol; 2009 Feb; 28(5):444-8. PubMed ID: 10229954
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
    Patsalos PN, Sander JW.
    Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.